As of 12/31/2024, Tracenable has captured detailed data on Gilead Sciences's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group. a
The dataset includes information on 81 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Gilead Sciences's consolidated operations. a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data. | USA | Subsidiary | Not Specified | 0000000 | 0000000 |
0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 81 entities. Get complete coverage in the full dataset. | |||||
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gilead Sciences’s data sources below and access millions more through our Disclosure Search.
Tracenable's group entities dataset provides geographic insights into Gilead Sciences's significant subsidiaries, revealing their location around the world. a
In total, the Gilead Sciences group includes 81 significant subsidiaries distributed across 42 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure. a
This visualization highlights the geographical distribution of Gilead Sciences's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape. a
In 2024, Tracenable identified that the Gilead Sciences group consisted of 81 significant subsidiaries, located across 42 countries. a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network. a
Gilead Sciences's significant subsidiaries are primarily located in Europe and North America, which together host 74.07% of its material entities. a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
Gilead Sciences exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance. a
Without full group hierarchy or equity details, it offers a restricted view of Gilead Sciences's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
No. Tracenable's data does not indicate any entities registered in jurisdictions typically categorized as low-tax or offshore financial centers, suggesting that Gilead Sciences's ownership network is primarily domiciled in standard corporate jurisdictions or that Gilead Sciences does not provide full transparency on its corporate structure. a